APA (7th ed.) Citation

MB, O., JH, J., M, N., JJ, L. v. B., RW, G., PW, P., . . . P, B. (2016). The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking. Journal of immunology (Baltimore, Md. : 1950), 197(3), 807. https://doi.org/10.4049/jimmunol.1501351

Chicago Style (17th ed.) Citation

MB, Overdijk, Jansen JH, Nederend M, Lammerts van Bueren JJ, Groen RW, Parren PW, Leusen JH, and Boross P. "The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking." Journal of Immunology (Baltimore, Md. : 1950) 197, no. 3 (2016): 807. https://doi.org/10.4049/jimmunol.1501351.

MLA (9th ed.) Citation

MB, Overdijk, et al. "The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking." Journal of Immunology (Baltimore, Md. : 1950), vol. 197, no. 3, 2016, p. 807, https://doi.org/10.4049/jimmunol.1501351.